Premier Physicians Weight Loss & Wellness Review: What Its GLP-1 Documentation Establishes

Premier Physicians Weight Loss & Wellness presents a broader medical practice than a medication subscription: offices in Las Vegas and Reno, physician-managed prescriptions, nutritional counseling, laboratory monitoring and related metabolic services. For an evidence-focused review, however, the important distinction is between documenting a service and demonstrating its results. The clinic’s public materials describe what it says it offers; they do not establish how much weight its patients lose, how consistently its follow-up occurs or what an individual’s complete treatment will cost.

The public documentation consulted October 19, 2026, also leaves two consequential questions unresolved. An oral GLP-1 advertisement starts at $149 without identifying the product or pricing period. Separately, the clinic’s FAQs advertise virtual initial consultations, while its terms require every new patient to complete an in-person consultation and physical evaluation. Neither issue proves poor care, but both affect whether a prospective patient can accurately understand the offer before arranging travel, providing insurance information or purchasing a membership.

At a glance

Practice and locations: Premier Physicians describes itself as an obesity medicine practice with offices in Las Vegas and Reno, Nevada; its credentials are provider statements, not independently verified here.
Sources: [8]
Named medicines: The clinic lists semaglutide as Ozempic and Wegovy and tirzepatide as Mounjaro and Zepbound, and says it prescribes only FDA-approved formulations.
Sources: [8]
Partial advertised price: Oral GLP-1 medications are advertised starting at $149, without a named product, pricing period, supply quantity or stated inclusions.
Sources: [4]
Conflicting entry requirements: FAQs offer new-patient telehealth consultations, but the terms require an initial in-person consultation and physical evaluation for all new patients.
Sources: [8] [5]
Cash-pay memberships: Six- and 12-month membership plans advertise priority appointments and autopay, but public materials do not establish their full prices or cancellation and refund rules.
Sources: [10] [8]

Start with the practice, not an assumed outcome

Premier Physicians identifies its founder as Dana Trippi, MD, whom it describes as dual board-certified in Emergency Medicine and Obesity Medicine with nearly 20 years of specialized experience. Those are meaningful professional claims to distinguish from anonymous prescribing marketing, but this review did not independently verify certifications or licenses. The practice also says board-certified physicians manage prescriptions within individualized plans. Its materials establish that representation, not that a particular physician will conduct every encounter.

The documented care model combines behavior modification, nutritional counseling, exercise planning and pharmacology when medically appropriate. Its program description says services may include medical evaluation, laboratory work, prescription medications, behavioral support and regular follow-up. “May include” matters: it is not a promise that every component comes with every appointment or membership. A prospective patient should obtain a written description of the selected program rather than treating the website’s full service menu as one bundled purchase.

This is the central evidence boundary throughout the review. A description of physician oversight is not a published assessment of oversight quality, and a comprehensive menu is not a measured patient outcome. Our guide to what public provider documents can prove explains that distinction. Premier’s documentation supports describing an identifiable Nevada weight-management practice; it does not support assigning a clinical success rate, a safety rating or superiority over competing clinics.

Sources: [8] [4]

The medication list does not identify the $149 oral offer

The practice names semaglutide under Ozempic and Wegovy and tirzepatide under Mounjaro and Zepbound. Its FAQs say both medicines require a physician evaluation and prescription, and that it prescribes only FDA-approved formulations. These are relatively specific statements about its intended prescribing model. Nevertheless, FDA approval belongs to particular products, not to Premier Physicians as a clinic, and the brand list does not establish which product a particular patient would receive.

The separate headline, “Now offering oral GLP-1 medications for weight loss! Starting at $149,” is substantially less specific. It does not identify the medicine, formulation, quantity, supply duration, eligibility conditions or included services. Nor does it explicitly connect the oral offer to any of the listed brands. The amount therefore cannot responsibly be labeled a monthly medication price, a complete program price or a medication benefit included in membership.

That missing connection is an evidence issue as well as a billing issue. Results associated with a named ingredient cannot automatically be transferred to an unidentified formulation or route. Readers can use our explanation of formulation and route evidence to frame the question: what exact product is being offered, and what evidence applies to that product? Premier directs readers to call for more information, making a written product-specific quotation the practical next step.

Sources: [8] [4] [1] [3]

Published drug research is not a Premier outcomes report

STEP 1 provides one useful example of the difference. This randomized trial involved 1,961 adults with obesity or overweight plus a weight-related condition, without diabetes, over 68 weeks. Both groups received lifestyle intervention. Mean weight change was −14.9% with studied subcutaneous semaglutide 2.4 mg weekly versus −2.4% with placebo. That dose identifies the study arm, not instructions for readers. Gastrointestinal events led to discontinuation in 4.5% and 0.8%, respectively; Novo Nordisk funded the trial.

Those results are not measurements of Premier Physicians’ patients. They do not establish results for the clinic’s unidentified oral offer, other routes, compounded preparations or an individual. The useful comparison is between the treatment actually proposed and the treatment actually studied—not between a clinic’s name and a published percentage. Our guide on clinical trials versus provider performance develops that distinction without treating a trial average as a personal prediction.

FDA’s separate guidance also requires careful boundaries. Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality; nonapproval alone does not establish clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Nothing in the consulted Premier documentation establishes that this clinic uses compounded drugs, so that general guidance should not be turned into an allegation about its prescribing.

Sources: [3] [1]

The first-visit contradiction changes the access picture

Premier advertises telehealth throughout Nevada for new-patient consultations, medication management, follow-up and ongoing support. It also says most weight-program services can occur virtually, including initial consultations, GLP-1 prescriptions and refills, laboratory-result review and treatment adjustments. Patients need a smartphone, tablet or computer with a camera and microphone. These statements describe a potentially convenient statewide service, but they do not settle whether someone can actually begin treatment without traveling.

The terms state: “All new patients must complete an initial consultation and physical evaluation in person at one of our office locations (Las Vegas or Reno).” That directly conflicts with the advertised virtual entry route. The consulted documentation does not explain exceptions, whether a preliminary video appointment precedes the required physical evaluation or which statement governs scheduling. Anyone relying on remote access should ask the office to reconcile both statements before paying or making arrangements.

There are clear contact routes for doing so: Las Vegas at (702) 822-7400 and Reno at (775) 657-6026. The terms give a contact address of 6930 S Cimarron Road, Suite 220, Las Vegas, NV 89113. These details help identify where to seek clarification, but the Nevada telehealth language should not be expanded into nationwide availability. Nor do the consulted pages establish appointment wait times, Spanish-language care or interpretation services.

Sources: [8] [5] [7]

Follow-up is described, but its operating details remain open

The clinic describes an initial assessment covering medical history, weight goals and existing health conditions. It says medication plans are individually monitored and adjusted using health history, laboratory work and response to treatment. Regular in-person or virtual visits are intended to evaluate progress, manage side effects and adjust treatment. These are substantive service descriptions, although the public materials do not set a follow-up interval, response-time standard or guaranteed appointment availability.

Premier also says it monitors bloodwork during the program to identify vitamin B12 deficiency and adjust the plan. That establishes a claimed monitoring practice, not a published laboratory schedule or confirmation that testing is included in a particular fee. NIDDK describes follow-up as addressing tolerance and response, with medication selection involving health conditions, other medicines, side effects and costs. Our guide to clinical follow-up explains why those responsibilities matter beyond processing prescription renewals.

The next part of the medication pathway is less documented. The consulted materials do not identify dispensing pharmacies, pickup procedures, shipping charges, delivery areas, cold-chain arrangements or dispensing and arrival timelines. A prescription service should not be assumed to include home delivery. If an injectable GLP-1 product does arrive warm or with insufficient refrigeration, FDA explicitly advises not using it and contacting the provider or dispensing pharmacy; that is general guidance, not evidence of a Premier delivery problem.

Sources: [12] [9] [2] [1]

Insurance and membership are different payment pathways

Premier says eligibility through insurance depends on the insurer, specific plan and other factors. Its list includes MGM Resorts, the Nevada Public Employees Benefits Plan for PPO plans only, United Healthcare PPO plans and Health Plan of Nevada Tier 2 PPO only, among others. These restrictions should survive any shorthand description that the clinic “accepts insurance.” Its scheduling department offers benefits checks, but accepting a consultation benefit does not establish that a prescribed medication is covered.

For uninsured or cash-pay patients, the practice advertises memberships providing access to physician consultations and medication management. Its membership page lists six- or 12-month plans, priority appointment access, autopay and “SAVINGS UP TO $900/YEAR.” That savings figure is the provider’s commercial claim; the consulted documentation does not disclose a sufficient comparison basis to verify it. The plan durations do not establish medication quantities, payment frequency, mandatory upfront collection or the consequences of leaving early.

A care coordinator can discuss current membership options and compare them with insurance coverage. Before enrollment, that conversation should produce actual amounts and written boundaries: the first charge, later charges, included visits, separate laboratory or medication bills, renewal terms and cancellation rights. Public documentation does not establish those details or refund rules. The following distinctions summarize what is known without replacing a personalized benefits check or written membership agreement.

What the advertised payment options establish
Option	Documented statement	Still needs confirmation
Oral GLP-1 offer	Starting at $149	Product, period, quantity and included fees
Insurance	Selected plans listed with restrictions	Individual benefits and medication coverage
Six-month membership	Priority appointments and autopay advertised	Price, billing interval and exit terms
12-month membership	Provider advertises savings up to $900/year	Comparison basis, renewal and refund rules
FibroScan	Insurance checks and private-pay options offered	Patient-specific coverage and charge

Sources: [6] [8] [10] [2]

Related services broaden the practice, not the proof of results

Premier advertises FibroScan at both its Las Vegas and Reno offices. It describes the liver-fat and stiffness scan as taking approximately 10 minutes, without needles or radiation, with results available immediately after the procedure. These are provider descriptions of the scan, not prescription-review or medication-delivery timelines. The clinic says coverage depends on the insurance plan and diagnosis, offers help checking benefits and notes private-pay options. It does not establish that the scan is included in a weight-management membership.

Other documented services include genetic testing for adults and pediatric patients in selected circumstances, such as a strong family history of obesity or lack of response to standard treatment. Premier also advertises nutritional and medical support for type 2 diabetes, prediabetes and insulin resistance within its weight program. These offerings explain the practice’s broader metabolic focus, but their availability does not show that every patient needs them or that they improve outcomes for every enrollee.

The practice explicitly does not perform bariatric surgery. Instead, it offers preoperative and postoperative evaluations and medical support, with a separate page naming coordination with surgical partners including Las Vegas Bariatrics. It also reports research participation with Wake Research Las Vegas and says eligible patients may access investigational treatments at no cost. Research participation should not be confused with free routine care, guaranteed trial eligibility or evidence that the clinic’s usual program has itself been tested.

Sources: [8] [11]

Communications and long-term care need separate agreements

Premier describes GLP-1 treatment as a long-term tool for many patients and says clinicians work on plans combining medication with behavioral and nutritional support. That describes a clinical approach, not a minimum purchase commitment. NIDDK likewise explains that treatment duration depends on response and side effects and that obesity may require long-term care. Neither statement establishes a fixed medication duration for an individual or promises maintained weight loss after treatment stops.

The clinic’s SMS terms cover appointment reminders, onboarding, insurance verification and follow-up logistics. Participants must be at least 18; a parent or legal guardian aged 18 or older must consent and register for a minor. Texting STOP ends the SMS service and triggers a confirmation message. It does not establish cancellation of medical appointments, prescriptions or membership billing. Keeping those permissions separate is important when evaluating what ongoing communication and financial commitments actually mean.

Although this review is for adults, Premier also advertises family-centered programs for patients under 18, requiring thorough clinical evaluation before medication and parental consent for minors. That is a distinct service, not evidence that every listed medicine is appropriate for every adolescent. Across both adult and family inquiries, the most useful preparation is a written care-and-payment outline: who evaluates the patient, where the first visit occurs, what is prescribed, what follow-up includes and how ongoing services end.

Sources: [8] [5] [2]

Questions & answers

Is Premier’s $149 oral GLP-1 offer a monthly price?

The advertisement does not establish that. It says “Starting at $149” without identifying a billing period, medicine, formulation, supply quantity or included services. Ask for a written quotation naming the exact product and separating consultation, laboratory, medication and membership charges. The documented amount should not be described as a complete monthly treatment cost.

Sources: [4]

Can a new Nevada patient start entirely through telehealth?

The public materials conflict. FAQs advertise virtual new-patient consultations, but the terms require every new patient to have an initial in-person consultation and physical evaluation in Las Vegas or Reno. Ask which requirement applies before booking. The documentation does not explain exceptions or establish that a remote consultation removes the physical-visit requirement.

Sources: [8] [5]

Does the clinic say it prescribes compounded semaglutide or tirzepatide?

Its FAQs say it prescribes only FDA-approved formulations, and it names Ozempic, Wegovy, Mounjaro and Zepbound. The consulted documentation does not identify a compounding partner or establish compounded prescribing. However, it also does not identify the oral product advertised from $149. That product requires direct clarification rather than an assumption based on either the brand list or general compounding concerns.

Sources: [8] [4]

Does an accepted insurance plan cover the medicine?

Not necessarily. Premier conditions program eligibility on the insurer and specific plan, and its list includes restrictions such as PEBP PPO only and Health Plan of Nevada Tier 2 PPO only. Scheduling staff offer benefits checks. Confirm consultation benefits, testing benefits and the exact prescription’s coverage separately; NIDDK notes that some plans cover weight-management medicines and others do not.

Sources: [6] [2]

What happens if I want to leave a membership early?

The consulted materials do not establish early-cancellation rights, penalties, automatic renewal provisions or refund rules for the six- and 12-month memberships. Request the agreement before authorizing payment and ask how unused services are treated. The SMS instruction to text STOP cancels messaging only; it is not a documented method for ending membership or recovering payments.

Sources: [10] [5]

Will Premier ship a prescription to my home?

Home delivery is not established by the consulted documentation. The materials describe prescribing and virtual refills but do not identify dispensing pharmacies, delivery fees, cold-chain procedures or arrival windows. Ask which pharmacy fills the prescription and whether pickup or shipping applies. FDA advises not using injectable GLP-1 medication that arrives warm or inadequately refrigerated and contacting the provider or pharmacy.

Sources: [8] [1]

Our assessment

Premier Physicians documents a recognizable Nevada medical practice with named prescription options, a multidisciplinary care model, insurance assistance and related metabolic services. Those details are more informative than a medication-price headline alone, but they remain service descriptions rather than independently measured evidence of patient outcomes. The most consequential unresolved points are the unidentified oral offer, conflicting first-visit requirements, incomplete membership terms and undocumented pharmacy pathway. A reasonable next step is to request a written product, access and payment outline—not to assume either that the clinic’s broad claims prove effectiveness or that missing public detail proves inadequate care. Published drug research can inform a clinician discussion, but it cannot substitute for identifying the actual treatment and responsibilities being offered.

Visit Premier Physicians Weight Loss & Wellness’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Premier Physicians Weight Loss & Wellness Review: What Its GLP-1 Documentation Establishes

At a glance

01Start with the practice, not an assumed outcome

02The medication list does not identify the $149 oral offer

03Published drug research is not a Premier outcomes report

04The first-visit contradiction changes the access picture

05Follow-up is described, but its operating details remain open

06Insurance and membership are different payment pathways

07Related services broaden the practice, not the proof of results

08Communications and long-term care need separate agreements